Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.72 |
| ▸ | PPP3CB | P16298 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.49 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13707453 | 1.00 | CTSB (0.72) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL3373234 | 0.95 | CTSB (0.73) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL13521369 | 0.95 | CTSB (0.73) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL14432927 | 0.94 | CTSB (0.74) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8353717 | 0.93 | CTSB (0.70) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8251091 | 0.93 | CTSB (0.74) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8353719 | 0.93 | CTSB (0.62) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8251578 | 0.92 | CTSB (0.69) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8249995 | 0.92 | CTSB (0.73) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8251319 | 0.92 | CTSB (0.73) | CTSBPPP3CBCYP3A4ABCC1ABCC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003064456-A1 | TRIPEPTIDES HAVING A HYDROXYPROLINE ETHER OF A SUBSTITUTED QUINOLINE FOR THE INHIBITION OF NS3 (HEPATITIS C) | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-08-07 | — | — | WO | disclosed |